Compare Morphine and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided ACB for Postoperative Analgesia After Knee Surgeries

ConditionsPostoperative Analgesia Morphine and Dexmedetomidine

Trial statusNot yet recruiting

Trial phasePhase 1, Phase 2

Trial typeInterventional

Biological sexAll

AgeNot listed

SponsorKafrelsheikh University

About this trial

This study aims to compare morphine and dexmedetomidine as adjuvants to bupivacaine in ultrasound-guided ACB for postoperative analgesia after knee surgeries

Eligibility criteria

Qualifiers

Both sexes.

American Society of Anesthesiologists (ASA) physical status I-II.

Body mass index (BMI) of 20-35 kg/m2.

Undergoing knee surgeries under spinal anesthesia.

Disqualifiers

Any known allergy or contraindication to local anesthetic.

History of substance abuse.

Decompansated cardiac, pulmonary, hepatic, renal disease.

Obese patients with BMI>35kg/m2.

Trial design

Treatments tested in this trial

Adductor Canal Block (ACB) Only

Treatment groups

15 Participants

are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Kafrelsheikh University

Lead sponsor

Source ClinicalTrials.gov